Source: Annual Congress 2007 - Biomarkers and assessment of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Stolz, M. Christ-Crain, N. Morgenthaler, D. Miedinger, J. Leuppi, R. Bingisser, C. Müller, J. Struck, B. Müller, M. Tamm (Basel, Switzerland; Hennigsdorf, Germany). Pro-adrenomedullin and pro-endothelin-1 for assessment and prognosis of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Eur Respir J 2007; 30: Suppl. 51, 413

Member's Comments

No comment yet.

Related content which might interest you: Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Eosinopenia as a prognostic factor in patients with acute exacerbation of chronic obstructive pulmonary disease. Source: International Congress 2017 – COPD and weaning Year: 2017 Characteristics and outcomes of hospitalizations for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Breathlessness during exacerbation of chronic obstructive pulmonary disease (ECOPD) and recovery Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications Year: 2019 Application of an outcome prediction model for hospitalized patients with exacerbation of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 55s Year: 2005 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Severity assessment in acute exacerbations of COPD Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005 The role of neutrophil/lymphocyte ratio in acute exacerbations of chronic obstructive pulmonary disease COPD Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Calorie-intake in patients hospitalized for an acute COPD exacerbation Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer Year: 2007 Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Proactive integrated care improves quality of life in patients with COPD Source: Eur Respir J 2009; 33: 1031-1038 Year: 2009 The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease) Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 7 Years survival of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 211s Year: 2001 Elevation of cardiac troponin-I predicts long-term mortality in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009